# SciSparc Ltd. (SPRC)

Source page: https://stoqly.net/companies/sprc

- **Ticker:** SPRC (Nasdaq)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001611746
- **Latest annual report:** 20-F filed 2026-04-29 (https://www.sec.gov/Archives/edgar/data/1611746/000121390026049322/ea0286030-20f_scisparc.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $0.68 on 2026-10-30
- **Revenue (FY2025):** $0.9M
- **Revenue growth:** −34.5%
- **Revenue growth, 5-year CAGR:** +28.7%
- **Gross margin:** 73.7%
- **Operating margin:** −978.3%
- **Net margin:** −1,422.8%
- **Return on invested capital:** −165,386.5%
- **Return on equity:** −196.5%
- **Net debt:** −$4.2M
- **Change in share count:** +303.2%
- **Piotroski F-score:** 2/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/sprc/figures.csv

| US$ millions | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | — | — | — | — | 0 | 0 | 1 | 3 | 1 | 1 |
| Operating income | -2 | -6 | -7 | -4 | -3 | -6 | -8 | -7 | -7 | -8 |
| Net income | 2 | 6 | 7 | 5 | 4 | -6 | -3 | -5 | -6 | -12 |
| Diluted EPS (US$) | 0.05 | 0.05 | 1.20 | 0.64 | 0.11 | 73.58 | 311.22 | 2,374.55 | 203.89 | 98.07 |
| Operating cash flow | -1 | -5 | -7 | -5 | -4 | -5 | -8 | -6 | -5 | -4 |
| Free cash flow | -1 | -5 | -7 | -5 | — | -5 | -8 | — | — | — |
| Cash | 1 | 9 | 1 | 1 | 2 | 7 | 4 | 2 | 2 | 5 |
| Debt and leases | — | — | — | — | 0 | — | — | — | — | 0 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.